Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
IRD Opus Genetics Inc.
- Stocks
- Healthcare
- NASDAQ: IRD
Price (delayed)
$1.105
Market cap
$65.93M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.1
Enterprise value
$24.13M
Highlights
The company's EPS rose by 2.3% QoQ
IRD's gross profit is down by 28% YoY but it is up by 24% QoQ
The revenue is down by 28% year-on-year but it is up by 24% since the previous quarter
Opus Genetics's equity has shrunk by 89% YoY and by 25% QoQ
The quick ratio has plunged by 78% YoY and by 40% from the previous quarter
Key stats
What are the main financial stats of IRD
Market
Valuations
Earnings
Shares outstanding
59.66M
Market cap
$65.93M
Enterprise value
$24.13M
Price to earnings (P/E)
N/A
Price to book (P/B)
9.91
Price to sales (P/S)
2.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.77
Revenue
$13.65M
Gross profit
$13.65M
Operating income
-$64.3M
Net income
-$58.62M
EBIT
-$58.62M
EBITDA
-$58.6M
Free cash flow
-$28.85M
Per share
Balance sheet
Liquidity
EPS
-$2.1
EPS diluted
-$2.1
Free cash flow per share
-$0.85
Book value per share
$0.11
Revenue per share
$0.4
TBVPS
$1.42
Total assets
$48.17M
Total liabilities
$24.25M
Debt
$0
Equity
$5.07M
Working capital
$23.68M
Debt to equity
0
Current ratio
1.98
Quick ratio
1.92
Net debt/EBITDA
0.71
Margins
Efficiency
Dividend
EBITDA margin
-429.3%
Gross margin
100%
Net margin
-429.4%
Operating margin
-471%
Return on assets
-137.7%
Return on equity
-270.3%
Return on invested capital
N/A
Return on capital employed
-245.1%
Return on sales
-429.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IRD stock price
How has the Opus Genetics stock price performed over time
Intraday
-2.21%
1 week
11.38%
1 month
13.92%
1 year
-43.77%
YTD
-7.14%
QTD
17.29%
Financial performance
How have Opus Genetics's revenue and profit performed over time
Revenue
$13.65M
Gross profit
$13.65M
Operating income
-$64.3M
Net income
-$58.62M
Gross margin
100%
Net margin
-429.4%
IRD's gross profit is down by 28% YoY but it is up by 24% QoQ
The revenue is down by 28% year-on-year but it is up by 24% since the previous quarter
Opus Genetics's net margin has increased by 18% QoQ
The operating margin has increased by 17% since the previous quarter
Price vs fundamentals
How does IRD's price correlate with its fundamentals
Growth
What is Opus Genetics's growth rate over time
Valuation
What is Opus Genetics stock price valuation
P/E
N/A
P/B
9.91
P/S
2.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.77
The company's EPS rose by 2.3% QoQ
The P/B is 147% above the last 4 quarters average of 4.1
Opus Genetics's equity has shrunk by 89% YoY and by 25% QoQ
The revenue is down by 28% year-on-year but it is up by 24% since the previous quarter
IRD's P/S is 7% below its last 4 quarters average of 3.0
Efficiency
How efficient is Opus Genetics business performance
Opus Genetics's return on equity has shrunk by 50% QoQ
The company's return on sales rose by 18% QoQ
IRD's ROA is down by 4.1% from the previous quarter
Dividends
What is IRD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IRD.
Financial health
How did Opus Genetics financials performed over time
Opus Genetics's total assets is 99% higher than its total liabilities
The total liabilities has surged by 115% since the previous quarter
The current ratio has dropped by 78% year-on-year and by 39% since the previous quarter
Opus Genetics's debt is 100% lower than its equity
Opus Genetics's equity has shrunk by 89% YoY and by 25% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.